Group One Trading’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,100
Closed -$6K 8813
2022
Q1
$6K Buy
9,100
+1,800
+25% +$1.53K ﹤0.01% 7424
2021
Q4
$9K Buy
7,300
+3,700
+103% +$6.57K ﹤0.01% 7431
2021
Q3
$8K Sell
3,600
-19,700
-85% -$42.8K ﹤0.01% 7618
2021
Q2
$64K Sell
23,300
-3,600
-13% -$8.95K ﹤0.01% 6371
2021
Q1
$70K Buy
26,900
+12,300
+84% +$34.8K ﹤0.01% 5964
2020
Q4
$41K Buy
14,600
+4,500
+45% +$13.1K ﹤0.01% 5143
2020
Q3
$47K Buy
10,100
+7,100
+237% +$23.4K ﹤0.01% 4693
2020
Q2
$8K Sell
3,000
-200
-6% -$641 ﹤0.01% 5240
2020
Q1
$8K Sell
3,200
-27,100
-89% -$97.8K ﹤0.01% 4655
2019
Q4
$155K Buy
30,300
+3,700
+14% +$20.5K ﹤0.01% 3343
2019
Q3
$172K Sell
26,600
-20,400
-43% -$141K ﹤0.01% 3188
2019
Q2
$293K Buy
47,000
+44,275
+1,625% +$337K ﹤0.01% 2581
2019
Q1
$29K Sell
2,725
-3,038
-53% -$30.3K ﹤0.01% 3866
2018
Q4
$46K Sell
5,763
-62
-1% -$894 ﹤0.01% 3610
2018
Q3
$113K Sell
5,825
-25,500
-81% -$464K ﹤0.01% 3447
2018
Q2
$566K Sell
31,325
-6,475
-17% -$95.5K ﹤0.01% 2196
2018
Q1
$402K Buy
37,800
+32,412
+602% +$521K ﹤0.01% 2222
2017
Q4
$227K Sell
5,388
-196,587
-97% -$8.82M ﹤0.01% 2842
2017
Q3
$11.1M Buy
201,975
+154,600
+326% +$26.1M 0.1% 231
2017
Q2
$8.79M Buy
47,375
+40,825
+623% +$7.16M 0.09% 237
2017
Q1
$783K Buy
6,550
+6,050
+1,210% +$634K 0.01% 1513
2016
Q4
$50K Sell
500
-50
-9% -$5.26K ﹤0.01% 3267
2016
Q3
$62K Buy
550
+500
+1,000% +$60K ﹤0.01% 3228
2016
Q2
$5K Sell
50
-1,763
-97% -$176K ﹤0.01% 4292
2016
Q1
$166K Sell
1,813
-1,275
-41% -$136K ﹤0.01% 2454
2015
Q4
$445K Buy
3,088
+225
+8% +$29.3K 0.01% 1908
2015
Q3
$296K Buy
+2,863
New +$336K ﹤0.01% 2210

Other funds holding SIOX

Group One Trading's SIOX Position: Q1 2023 in Review

Group One Trading sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 902 shares — an estimated $392 sold.

Group One Trading first reported a position in SIOX in Q4 2015 and held it in 25 quarters. The position peaked at $2.07M in Q3 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Group One Trading reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 902 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $392.
  • Group One Trading first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 25 quarters.
  • Group One Trading's Sio Gene Therapies Inc. Common Stock position peaked at $2.07M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.